However, to date, most FOXM1 expression studies in cancer, including ovarian cancer, have only reported overall FOXM1 protein levels rather than phosphorylated FOXM1 (phospho-FOXM1), which stems from a limited number of antibodies available for PTMs. Here, FOXM1 is linked to ovarian carcinoma.